What is Insmed's total equity?

Insmed (INSM) reported total equity of $704.85M in Q1 2026.

How has Insmed's total equity changed year-over-year?

Insmed's total equity increased by 610.8% year-over-year, from $99.16M to $704.85M.

What is the long-term trend for Insmed's total equity?

Over 5 years (2020 to 2025), Insmed's total equity has grown at a 21.8% compound annual growth rate (CAGR), from $275.88M to $738.98M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Insmed INSM Total Equity

Total Equity at other companies

Sarepta Therapeutics, Inc.SRPT

$1.51B+31.7%

United TherapeuticsUTHR

$5.9B-13.3%

Solid Biosciences Inc.SLDB

$374.13M+27.1%

ANI PharmaceuticalsANIP

$562.3M+34.3%

Regeneron PharmaceuticalsREGN

$31.42B+6.9%

SavaraSVRA

$176.04M+19.1%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total assets$2.1B+15.2%

Cash flow

See full

Operating cash flow-$222.7M+15.0%

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$23.11B+25.2%

Enterprise value$23.11B+29.9%

P/S28.2×-18.2×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's total equity?: Insmed (INSM) reported total equity of $704.85M in Q1 2026.
How has Insmed's total equity changed year-over-year?: Insmed's total equity increased by 610.8% year-over-year, from $99.16M to $704.85M.
What is the long-term trend for Insmed's total equity?: Over 5 years (2020 to 2025), Insmed's total equity has grown at a 21.8% compound annual growth rate (CAGR), from $275.88M to $738.98M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.